Completion of Sales. A sale of a Unit shall be deemed by the Company to be completed for purposes of Section 3(d) if and only if (i) a properly completed and executed Subscription Agreement, together with payment of the full purchase price of each purchased Units (which includes the applicable Selling Commissions and Marketing Expense Allowances) has been received, from an investor who satisfies the applicable suitability standards and minimum purchase requirements set forth in the Registration Statement as determined by the Dealer Manager, in accordance with the provisions of this Agreement, (ii) the Company has accepted such subscription, and (iii) such investor has been admitted as a unitholder of the Company (the date of such completion, a “Closing Date”). The Dealer Manager hereby acknowledges and agrees that (i) the Company, in its sole and absolute discretion, may accept or reject any subscription, in whole or in part, for any reason whatsoever or no reason, (ii) no Selling Commission or Marketing Expense Allowance will be paid to the Dealer Manager with respect to that portion of any subscription which is rejected and (iii) the Company is acting as an intermediary with respect to the Selling Commissions and Marketing Expense Allowances payable to the Dealer Manager, and shall pay amounts to the Dealer Manager in accordance with this Agreement if received from an investor in connection with its purchase of Units. The initial Closing Date shall not occur until (i) the Company is prepared to accept Subscription Agreements for a minimum of $100,000,000 of Units, (ii) all funds for such subscriptions have been duly deposited in the Escrow Account and (iii) all subscriber checks made payable to the Dealer Manager for any portion of the subscription funds have been received by the Dealer Manager after having cleared the banking system. If less than all the Units shall have been subscribed and paid for at the initial Closing Date, then subsequent Closing Dates will take place at such times, dates and places as determined by the Company, with the concurrence of the Dealer Manager. Units will be issued to subscribers and compensation will be paid to the Dealer Manager upon each Closing Date.
Completion of Sales. All sales of Product (other than a Product in a Future Indication as to which Alexion has Opted Out and not Opted Back In) will be completed, distributed, accounted for, billed and booked by Alexion at prices established by Alexion.
Completion of Sales. All sales of Collaboration Products will be completed, distributed, accounted for, billed and booked by Warner at prices established by Warner.
Completion of Sales. All sales of Warner-LeukoSite Products will be completed, distributed, accounted for, billed and booked by Warner at prices established by Warner, provided, however, that Warner will not grant a preference to or otherwise favor other products of Warner over Warner-LeukoSite Products or Warner Products based on the fact LeukoSite is entitled to royalties or a share of Co-promotion rights.
Completion of Sales. Except as otherwise agreed to by the parties, CMI shall be solely responsible for undertaking and completing the actual sale and invoicing of all Systems in North America and the collection of accounts receivable therefrom; provided that, in those instances where Medtronic reasonably believes it is necessary for Medtronic to invoice sales of Systems to a customer under Medtronic's "strategic alliance" sales program (in order for Medtronic to obtain credit under such program for the sale of such System), CMI and Medtronic shall cooperate to have CMI invoice Medtronic for such Systems and thereby allow Medtronic to invoice the sales of Systems to such "strategic alliance" customer. In such event, Medtronic shall pay CMI the price quoted by CMI to Medtronic or such customer for the Systems so purchased by Medtronic. Such payment shall be due and payable 60 days after CMI's invoice date.
Completion of Sales. 18 7.11 Training . . . . . . . . . . . . . . . . . . . . . . . . .18 7.12 Exchange of Marketing Information. . . . . . . . . . . . .18 ARTICLE 8. FDA. . . . . . . . . . . . . . . . . . . . . . . . . .19
Completion of Sales. All sales of the Product will be completed, distributed, accounted for, billed and booked by Wyeth-Ayerst.
